These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
317 related articles for article (PubMed ID: 27117536)
1. Clinical, pathological and genetic features of follicular lymphoma grade 3A: a joint analysis of the German low-grade and high-grade lymphoma study groups GLSG and DSHNHL. Koch K; Hoster E; Ziepert M; Unterhalt M; Ott G; Rosenwald A; Hansmann ML; Bernd W; Stein H; Pöschel V; Dreyling M; Trümper L; Löffler M; Schmitz N; Hiddemann W; Pfreundschuh M; Klapper W Ann Oncol; 2016 Jul; 27(7):1323-9. PubMed ID: 27117536 [TBL] [Abstract][Full Text] [Related]
2. Follicular lymphoma grade 3B is a distinct neoplasm according to cytogenetic and immunohistochemical profiles. Horn H; Schmelter C; Leich E; Salaverria I; Katzenberger T; Ott MM; Kalla J; Romero M; Siebert R; Rosenwald A; Ott G Haematologica; 2011 Sep; 96(9):1327-34. PubMed ID: 21659362 [TBL] [Abstract][Full Text] [Related]
3. Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3. Ott G; Katzenberger T; Lohr A; Kindelberger S; Rüdiger T; Wilhelm M; Kalla J; Rosenwald A; Müller JG; Ott MM; Müller-Hermelink HK Blood; 2002 May; 99(10):3806-12. PubMed ID: 11986240 [TBL] [Abstract][Full Text] [Related]
4. Follicular lymphoma in Taiwan: a low frequency of t(14;18), with grade 3A tumours more closely related to grade 3B than to low-grade tumours. Chang ST; Lu YH; Lu CL; Kuo SY; Liu H; Lin SH; Win KT; Hsieh YC; Chuang SS Histopathology; 2013 Jul; 63(1):1-12. PubMed ID: 23631722 [TBL] [Abstract][Full Text] [Related]
6. Immunophenotypic features and t(14;18) (q32;q21) translocation of Chinese follicular lymphomas helps to distinguish subgroups. Zhang F; Yan LX; Lin SX; Ye ZY; Zhuang HG; Yun JP; Lin HL; Luo DL; Xu FP; Luo XL; Cheng J; Zhang KP; Liu YH Diagn Pathol; 2013 Sep; 8():154. PubMed ID: 24047469 [TBL] [Abstract][Full Text] [Related]
7. Follicular lymphoma grade 3B includes 3 cytogenetically defined subgroups with primary t(14;18), 3q27, or other translocations: t(14;18) and 3q27 are mutually exclusive. Bosga-Bouwer AG; van Imhoff GW; Boonstra R; van der Veen A; Haralambieva E; van den Berg A; de Jong B; Krause V; Palmer MC; Coupland R; Kluin PM; van den Berg E; Poppema S Blood; 2003 Feb; 101(3):1149-54. PubMed ID: 12529293 [TBL] [Abstract][Full Text] [Related]
9. Gene expression profiling reveals a close relationship between follicular lymphoma grade 3A and 3B, but distinct profiles of follicular lymphoma grade 1 and 2. Horn H; Kohler C; Witzig R; Kreuz M; Leich E; Klapper W; Hummel M; Loeffler M; Trümper L; Spang R; Rosenwald A; Ott G; Haematologica; 2018 Jul; 103(7):1182-1190. PubMed ID: 29567771 [TBL] [Abstract][Full Text] [Related]
10. Grade 3 Follicular Lymphoma: Outcomes in the Rituximab Era. Mustafa Ali M; Rybicki L; Nomani L; Rouphail B; Dean RM; Hill BT; Jagadeesh D; Pohlman B; Hsi ED; Smith MR Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):797-803. PubMed ID: 28789937 [TBL] [Abstract][Full Text] [Related]
11. Follicular non-Hodgkin's lymphoma: correlation between histology, pathophysiology, cytogenetic, prognostic factors, treatment, survival. Găman AM Rom J Morphol Embryol; 2013; 54(1):71-6. PubMed ID: 23529311 [TBL] [Abstract][Full Text] [Related]
12. Cytogenetic alterations affecting BCL6 are predominantly found in follicular lymphomas grade 3B with a diffuse large B-cell component. Katzenberger T; Ott G; Klein T; Kalla J; Müller-Hermelink HK; Ott MM Am J Pathol; 2004 Aug; 165(2):481-90. PubMed ID: 15277222 [TBL] [Abstract][Full Text] [Related]
13. [Genetic and biological features define two types of follicular non-Hodgkin grade 3 lymphoma]. Katzenberger T; Lohr A; Ott MM; Kalla J; Rosenwald A; Müller-Hermelink HK; Ott G Verh Dtsch Ges Pathol; 2000; 84():153-61. PubMed ID: 11217435 [TBL] [Abstract][Full Text] [Related]
14. Low-grade follicular lymphoma with t(14;18) presents a homogeneous disease entity otherwise the rest comprises minor groups of heterogeneous disease entities with Bcl2 amplification, Bcl6 translocation or other gene aberrances. Guo Y; Karube K; Kawano R; Yamaguchi T; Suzumiya J; Huang GS; Ohshima K Leukemia; 2005 Jun; 19(6):1058-63. PubMed ID: 15815725 [TBL] [Abstract][Full Text] [Related]
15. Double-hit follicular lymphoma with MYC and BCL2 translocations: a study of 7 cases with a review of literature. Miao Y; Hu S; Lu X; Li S; Wang W; Medeiros LJ; Lin P Hum Pathol; 2016 Dec; 58():72-77. PubMed ID: 27544800 [TBL] [Abstract][Full Text] [Related]
16. Bendamustine plus Rituximab Versus R-CHOP as First-Line Treatment for Patients with Follicular Lymphoma Grade 3A: Evidence from a Multicenter, Retrospective Study. Mondello P; Steiner N; Willenbacher W; Cerchione C; Nappi D; Mauro E; Ferrero S; Cuzzocrea S; Mian M Oncologist; 2018 Apr; 23(4):454-460. PubMed ID: 29317554 [TBL] [Abstract][Full Text] [Related]
17. A clinicopathologic evaluation of follicular lymphoma grade 3A versus grade 3B reveals no survival differences. Hsi ED; Mirza I; Lozanski G; Hill J; Pohlman B; Karafa MT; Coupland R Arch Pathol Lab Med; 2004 Aug; 128(8):863-8. PubMed ID: 15270618 [TBL] [Abstract][Full Text] [Related]
18. Utility of immunohistochemistry with an antibody against MYC at the initial diagnosis of follicular lymphoma, grade 3A, for predicting a more aggressive clinical course: a case report and review of the literature. Ichikawa K; Aritaka N; Ogura K; Hosone M; Ota Y; Sato E; Komatsu N; Hirano T Int J Clin Exp Pathol; 2015; 8(6):7559-64. PubMed ID: 26261669 [TBL] [Abstract][Full Text] [Related]
19. Non-Hodgkin lymphoma with t(14;18): clonal evolution patterns and cytogenetic-pathologic-clinical correlations. Aamot HV; Torlakovic EE; Eide MB; Holte H; Heim S J Cancer Res Clin Oncol; 2007 Jul; 133(7):455-70. PubMed ID: 17235551 [TBL] [Abstract][Full Text] [Related]
20. Outcome of follicular lymphoma grade 3: is anthracycline necessary as front-line therapy? Chau I; Jones R; Cunningham D; Wotherspoon A; Maisey N; Norman AR; Jain P; Bishop L; Horwich A; Catovsky D Br J Cancer; 2003 Jul; 89(1):36-42. PubMed ID: 12838297 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]